Neutrophil gelatinase–associated lipocalin (NGAL) as a Biomarker for Early Acute Kidney Injury
Authors:
- 1 April 2011
- journal article
- review article
- Published by Elsevier in Critical Care Clinics
- Vol. 27 (2) , 379-389
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Serum Neutrophil Gelatinase-Associated Lipocalin Correlates With Kidney Function in Heart Allograft RecipientsTransplantation Proceedings, 2010
- Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU populationIntensive Care Medicine, 2009
- Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery—A prospective cohort study*Critical Care Medicine, 2009
- Neutrophil Gelatinase-Associated Lipocalin Is a New and Sensitive Marker of Kidney Function in Chronic Kidney Disease Patients and Renal Allograft RecipientsTransplantation Proceedings, 2009
- Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgeryKidney International, 2008
- Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shockCritical Care Medicine, 2008
- Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injuryCritical Care, 2007
- Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: a novel marker of renal injuryPediatric Nephrology, 2006
- Differential gene expression following early renal ischemia/reperfusionKidney International, 2003
- Hospital-acquired renal insufficiency: A prospective studyThe American Journal of Medicine, 1983